Highly potent nociceptin analog containing the Arg-Lys triple repeat

Area of Science:

• Pharmacology
• Neuroscience
• Biochemistry

Background:

• Nociceptin, a neuropeptide, features Arg-Lys (RK) residues crucial for binding to the ORL1 receptor.
• The RK residues are hypothesized to interact with acidic amino acid clusters in the receptor's second extracellular loop.

Purpose of the Study:

• To design and synthesize nociceptin analogs with enhanced binding affinity to the ORL1 receptor's acidic cluster.
• To investigate the structure-activity relationship of novel nociceptin analogs containing repeated RK dipeptide units.

Main Methods:

• Synthesis of nociceptin analogs with RK dipeptide units at positions 6-7, 10-11, and 14-15.
• Evaluation of receptor binding affinity using a standard binding assay.
• Assessment of functional activity via [(35)S]GTPgammaS binding assays.

Main Results:

• Nociceptin analogs with RK at positions 6-7 and 10-11 showed weak to moderate activity.
• [Arg-Lys(14-15)]nociceptin demonstrated significantly enhanced potency, being 3-fold in binding and 17-fold in functional assays compared to parent nociceptin.
• This analog was the first to exhibit superior activity over the parent nociceptin.

Conclusions:

• The [Arg-Lys(14-15)]nociceptin analog represents a potent modulator of the ORL1 receptor.
• Structure-activity relationship studies suggest the RK(14-15) moiety interacts with the receptor's acidic amino acid cluster or aromatic residues.